Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.90
Delayed Data
As of May 27
 -0.07 / -0.78%
Today’s Change
4.15
Today|||52-Week Range
10.74
+4.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-3.3M-4.2M-5.7M-7.2M
 
 
 
 
 
Depreciation14.7K5.4K6.0K4.0K
 
 
 
 
 
Total Other Cash Flow768.5K1.2M1.5M1.4M
 
 
 
 
 
Funds From Operations-2.6M-3.0M-4.2M-5.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-259.7K353.3K-161.0K-862.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.3M-3.4M-4.1M-4.9M
 
 
 
 
 
 
InvestingIncrease In Investments-475.4K-5.8M-55.8M-1.9M
 
 
 
 
 
Decrease In Investments2.3M1.3M42.7M19.7M
 
 
 
 
 
Capital Expenditures-2.1K-6.4K-14.0K-1.0K
 
 
 
 
 
Other Investing - Uses-3.6K-2.1K-2.0K-21.1M
 
 
 
 
 
Other Investing - Sources0.004.9K2.0K0.00
 
 
 
Net Cash Flow Investing1.8M-4.6M-13.1M-3.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.5M5.8M16.6M9.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.5M5.8M16.6M9.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-38.9K-18.1K6.0K-12.0K
 
 
 
 
 
 
Net Change In Cash3.0M-2.1M-516.0K1.5M